Skip to main content

Venture Kick — Portfolio, Page 16

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

474
Companies
$1.6B
Total invested
$3.9M
Avg. check
41
Industries
Biotechnology 11Health Care 9Medical 7Manufacturing 4Life Science 4Renewable Energy 3+35 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 361384 of 474
Bionomous
September 2024

Bionomous automates the screening, sorting, and plating of miniature biological entities to accelerating science

Biotechnology · Villaz-saint-pierre$3.5M Debt Financing
WattAnyWhere
September 2024

WattAnyWhere provides a 300kw fuel cell-based, pollutant-free generator that converts ethanol into clean electricity.

Clean Energy · Sion$445K Debt Financing
Orio Therapeutics
September 2024

Orio Therapeutics is a biotechnology research company that offers treatment and medication support for patients with myocardial infarction.

Biotechnology · Monthey$118K Convertible Note
YLAH
September 2024

YLAH provides professionals with a tool to assist and develop individual therapies.

Health Care · Bern$589K Series Unknown
NaturLoop
September 2024

NaturLoop is a Swiss-based cleantech and material science company.

Environmental Engineering · Biel$1.0M Seed
CompagOs
September 2024

CompagOs is developing a blood-based test to help oncologists detect bone metastases early with mineralized bone models.

Oncology · Hünenberg$117K Convertible Note
Idunox
August 2024

The most comprehensive blood test, via multi-omics and AI, for disease risk identification and prevention planning.

Bioinformatics · Allschwil$4K Grant
TrueYouOmics
August 2024

The most comprehensive blood test, via multi-omics and AI, for disease risk identification and prevention planning.

Bioinformatics · Winterthur$4K Grant
Matriq
July 2024

Matriq is a manufacturing frim that designs automated machines for the marking and coding of plastics during the injection molding process.

Industrial Automation · Saint Gallen$1.1M Seed
Regenosca
July 2024

Regenosca develops biomaterials serving as an alternative to autologous tissue substitutes for soft tissue repair.

Biotechnology · Lausanne$1.1M Pre-Seed
Scrona
July 2024

Scrona is a manufacturing company that focuses on developing a wide range of semiconductor products.

Manufacturing · Zürich$4.0M Convertible Note
Aspivix
June 2024

ASPIVIX is developing a device that makes gynecological procedures more comfortable for patients.

Biotechnology · Renens$556K Debt Financing
NXI Therapeutics
June 2024

NXI Therapeutics develops next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.

Biotechnology · Basel$4.0M Pre-Seed
SmartCardia
May 2024

SmartCardia's patch and cloud SaaS platform is a single solution for complete cardiology practice and remote patient monitoring

Apps · LausanneNon Equity Assistance
Cowa Thermal Solutions
May 2024

Cowa Thermal Solutions develops thermal energy storage technology based on phase-change materials.

Energy · Horw$2.1M Series Unknown
Correntics
May 2024

Reimagining the future: Empowering organizations to weather the storm and thrive.

Risk Management · Zürich$1.6M Grant
Taskbase
May 2024

Taskbase is an e-learning technology company that uses AI to empower adaptive tutoring using advanced formative feedback systems.

Artificial Intelligence (AI) · Zürich$3.9M Series A
Isospec Analytics
April 2024

Isospec Analytics is a life science company that aims at simplifying molecular identification with biotechnology research.

Biotechnology · Lausanne$110K Debt Financing
Bcomp
April 2024

Bcomp is a textile manufacturing company that provides natural fibred reinforcements for the motorsport, mobility, and aerospace industry.

Automotive · Fribourg$39.4M Series C
Volumina Medical
March 2024

Volumina Medical is a healthcare technology company that engages develops injectable 3D scaffolds for the reconstruction of soft tissues.

Biotechnology · Epalinges$21.0M Series A
Hemotune
March 2024

Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.

Biotechnology · Schlieren$15.6M Series B
Terapet
March 2024

Geneva-based MedTech spin-off from CERN, specializing in the development and manufacturing of innovative nuclear imaging systems.

Health Care · Geneva$1.8M Grant
FimmCyte
February 2024

FimmCyte is a biotechnology company that engages in the research and treatment of chronic endometriosis disease.

Biotechnology · Basel$1.1M Convertible Note
Maven Health
February 2024

Maven health is a technology company that offers noninvasive saliva tests for metabolic health assessments for healthcare providers

Analytics · Lausanne$11K Grant

Where Venture Kick invests

Biotechnology11
Health Care9
Medical7
Manufacturing4
Life Science4
Renewable Energy3

About Venture Kick's portfolio

How many companies has Venture Kick invested in?

Venture Kick has invested in 474 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Venture Kick invest in?

Venture Kick's top investment sectors include Biotechnology, Health Care, Medical, Manufacturing, Life Science. The firm invests across 41 different industry categories.

What is Venture Kick's largest investment?

Among tracked funding rounds, Bcomp received $39.4M in a Series C round. Venture Kick's total known invested capital is $1.6B.

What is the average investment size for Venture Kick?

Venture Kick's average investment size is $3.9M across its portfolio of 474 companies.

What are Venture Kick's most recent investments?

Recent Venture Kick portfolio additions include Bionomous, WattAnyWhere, Orio Therapeutics, YLAH, NaturLoop. These companies were founded in 2020 or later.

Reach the founders behind these 474 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →